NCT07043621

Brief Summary

This study aims to evaluate the effect of scalp block timing-whether administered preoperatively or postoperatively-on postoperative recovery quality in patients undergoing craniotomy. The recovery quality will be assessed using the validated Quality of Recovery-40 (QoR-40) questionnaire. A total of 60 patients, aged 18-80 years, classified as ASA I-III and with a Glasgow Coma Scale (GCS) score of 15 upon admission to the recovery unit, will be enrolled. The primary outcome is the QoR-40 score. Secondary outcomes include hemodynamic changes and pain intensity measured by the Visual Analog Scale (VAS).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2025

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

June 18, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 29, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

June 29, 2025

Status Verified

June 1, 2025

Enrollment Period

5 months

First QC Date

June 18, 2025

Last Update Submit

June 27, 2025

Conditions

Keywords

Scalp BlockCraniotomy surgeryanalgesiapostoperative pain

Outcome Measures

Primary Outcomes (1)

  • Quality of Recovery Score

    Patient recovery will be assessed using the validated Turkish version of the QoR-40 (Quality of Recovery-40) questionnaire, a 40-item Likert-type scale covering five domains: emotional state, physical comfort, psychological support, physical independence, and pain. The total score ranges from 40 (poor recovery) to 200 (excellent recovery).

    The observation period extended from the beginning of surgery until 24 hours postoperatively.

Secondary Outcomes (4)

  • Perioperative Hemodynamic Changes

    Intraoperative (Hemodynamic parameters were monitored from the beginning to the end of surgery.)

  • Perioperative Hemodynamic Changes

    Intraoperative (Hemodynamic parameters were monitored from the beginning to the end of surgery.)

  • Intraoperative and Postoperative Opioid Consumption

    Total opioid consumption will be recorded intraoperatively and within the first 24 hours postoperatively.

  • Postoperative Pain Scores

    10 minutes, 2 hours, 6 hours, and 24 hours postoperatively

Other Outcomes (1)

  • Adverse effects

    Postoperative 24 hours

Study Arms (2)

Early Scalp Block Group

ACTIVE COMPARATOR

Patients in this group will receive a scalp block with 0.25% bupivacaine (20 mL) administered under ultrasound guidance after the induction of general anesthesia but prior to head pinning

Procedure: Early Scalp Block Group

Postoperative Scalp Block Group

ACTIVE COMPARATOR

Patients in this group will receive a scalp block with 0.25% bupivacaine (20 mL) administered under ultrasound guidance at the end of surgery, before emergence from anesthesia.

Procedure: Late Scalp Block Group

Interventions

Following induction of general anesthesia and prior to head pinning (Mayfield clamp placement), a scalp block was performed under aseptic conditions using 20 mL of 0.25% bupivacaine. The block targeted six sensory nerves that innervate the scalp: Supraorbital nerve, Supratrochlear nerve, Auriculotemporal nerve ,Zygomaticotemporal nerve, Greater occipital nerve, Lesser occipital nerve. Each nerve was infiltrated subcutaneously at its anatomical location using a 25-gauge needle, with the total volume distributed evenly or proportionally across the injection sites.

Also known as: Pre-pinning Scalp Block Group
Early Scalp Block Group

In the pre-emergence group, the scalp block was performed at the end of surgery but before emergence from general anesthesia, while the patient was still under deep anesthesia. Under strict aseptic conditions, 20 mL of 0.25% bupivacaine was administered to block the following six sensory nerves innervating the scalp: Supraorbital nerve, Supratrochlear nerve, Auriculotemporal nerve, Zygomaticotemporal nerve, Greater occipital nerve, Lesser occipital nerve. The local anesthetic was injected subcutaneously at the anatomical landmarks of each nerve using a 25-gauge needle. The total volume was distributed evenly or proportionally depending on the area. No additional surgical stimulation occurred after the block, and extubation followed routine emergence from anesthesia.

Also known as: Pre-emergence Scalp Block Group
Postoperative Scalp Block Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged between 18 and 80 years.
  • Scheduled for craniotomy under general anesthesia.
  • ASA physical status classification I to III.
  • Glasgow Coma Scale (GCS) score of 15 at the time of emergence from anesthesia.
  • Provide informed consent to participate in the study.

You may not qualify if:

  • Chronic use of analgesic medications prior to surgery.
  • Glasgow Coma Scale (GCS) score below 15 postoperatively.
  • Allergy or hypersensitivity to local anesthetics or opioids used in the study.
  • Contraindications for scalp block or patient-controlled analgesia.
  • Patients with severe hepatic, renal, or cardiac dysfunction.
  • Patients unable to comprehend or complete the QoR-40 questionnaire.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sakarya University Training and Research Hospital

Sakarya, 54290, Turkey (Türkiye)

Location

MeSH Terms

Conditions

AgnosiaPain, Postoperative

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesPain

Central Study Contacts

Muhammed halit TEKECİ

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
A blinded investigator will monitor intraoperative hemodynamics, evaluate opioid/analgesic use, and assess postoperative recovery using the QoR-40 questionnaire.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: A total of 60 patients undergoing elective craniotomy will be randomly assigned to one of two parallel groups (n=30 per group). Group 1 will receive a preoperative scalp block, while Group 2 will receive a postoperative scalp block. A blinded investigator will monitor intraoperative hemodynamic parameters and assess both intraoperative and postoperative opioid and analgesic consumption. Postoperatively, all patients will complete the validated Quality of Recovery-40 (QoR-40) questionnaire to evaluate recovery outcomes. The study aims to compare the effect of scalp block timing on postoperative recovery and analgesic requirements.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiology and Reanimation Specialist, M.D.

Study Record Dates

First Submitted

June 18, 2025

First Posted

June 29, 2025

Study Start

June 1, 2025

Primary Completion

November 1, 2025

Study Completion

December 1, 2025

Last Updated

June 29, 2025

Record last verified: 2025-06

Locations